A Global Perspective on Cardiovascular Disease in Vulnerable Populations

Canadian Journal of Cardiology

Volumn 31, Issue 9, 2015, Pages 1081-1093

  Yeates, Karen ^a   Lohfeld, Lynne ^b   Sleeth, Jessica ^a   Morales, Fernando ^c   Rajkotia, Yogesh ^d   Ogedegbe, Olugbenga ^e  

^a QUEEN S UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Mailman School of Public Health ^*  (United States)

^d Thinkwellglobal   (Mozambique)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEMOGRAPHY; DEVELOPING COUNTRY; ECONOMIC ASPECT; EPIDEMIC; ETHNIC GROUP; FUNDING; HIGH RISK POPULATION; HUMAN; INDIGENOUS PEOPLE; PRIMARY PREVENTION; PRISONER; REVIEW; RISK FACTOR; SOCIAL DETERMINANTS OF HEALTH; VULNERABLE POPULATION; CARDIOVASCULAR DISEASES; DIET; DISEASE COURSE; DRINKING BEHAVIOR; HEALTH; LIFESTYLE; POVERTY; SMOKING; STATISTICS AND NUMERICAL DATA; TELEMEDICINE;

ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; DIET; DISEASE PROGRESSION; GLOBAL HEALTH; HUMANS; LIFE STYLE; POVERTY; RISK FACTORS; SMOKING; SOCIAL DETERMINANTS OF HEALTH; TELEMEDICINE; VULNERABLE POPULATIONS;

EID: 84940727746     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.06.035     Document Type: Review

References (127)

1. World Health Organization. Noncommunicable diseases. Available at:. Accessed April 15, 2015. http://www.who.int/topics/noncommunicable_diseases/en.
2. Political declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases - Resolution adopted by the General Assembly 2011, United Nations, United Nations, New York.
3. Hunter D.J., Reddy K.S. Noncommunicable diseases. N Engl J Med 2013, 369:1336-1343.
4. Beaglehole R., Bonita R., Horton R., et al. Priority actions for the non-communicable disease crisis. Lancet 2011, 377:1438-1447.
5. Lozano R., Naghavi M., Foreman K., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
6. Murray C.J., Vos T., Lozano R., et al. Disability-adjusted life-years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
7. The global burden of disease: 2004 update 2008, World Health Organization, World Health Organization, Geneva.
8. Mendis S., Banerjee A. Cardiovascular disease: equity and social determinants. Equity, Social Determinants and Public Health Programmes 2010, 31-48. WHO, Geneva. E. Blas, A.S. Kurup (Eds.).
9. Lynch J.W., Kaplan G.A., Salonen J.T. Why do poor people behave poorly? Variation in adult health behaviours and psychosocial characteristics by stages of the socioeconomic lifecourse. Soc Sci Med 1997, 44:809-819.
10. Mackenbach J.P., Stirbu I., Roskam A.J., Schaap M.M., Menvielle G. Socioeconomic inequalities in health in 22 European countries. N Engl J Med 2008, 358:2468-2481.
11. Bovet P., Paccaud F. Cardiovascular disease and the changing face of global public health: a focus on low and middle income countries. Public Health Rev 2012, 33:397-415.
12. 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases 2008, World Health Organization, WHO, Geneva.
13. The Growing Danger of Non-Communicable Diseases - Acting Now to Reverse Course 2011, The World Bank, The World Bank, Washington DC.
14. From Burden to "Best Buys": Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries 2011, World Health Organization and World Economic Forum, WHO and World Economic Forum, Geneva.
15. Non-Communicable Diseases: a Priority For Women's Health and Development 2011, The NCD Alliance, World Heart Federation (with the International Diabetes Federation, the International Union Against Cancer, and the Framework Convention Alliance).
16. McGill H.C., McMahan C.A., Gidding S.S. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation 2008, 117:1216-1227.
17. Wandera S.O., Kwagala B., Ntozi J. Prevalence and risk factors for self-reported non-communicable diseases among older Ugandans: a cross-sectional study. Glob Health Action 2015, 8:27923.
18. Hayes D.K., Denny C.H., Keenan N.L., et al. Racial/ethnic and socioeconomic differences in multiple risk factors for heart disease and stroke in women: behavioral risk factor surveillance system, 2003. J Womens Health (Larchmt) 2006, 15:1000-1008.
19. Martikainen P., Mäkelä P., Koskinen S., Valkonen T. Income differences in mortality: a register-based follow-up study of three million men and women. Int J Epidemiol 2001, 30:1397-1405.
20. Marmot M. Economic and social determinants of disease. Bull World Health Organ 2001, 79:988-989.
21. Kuper H., Adami H.O., Theorell T., Weiderpass E. The socioeconomic gradient in the incidence of stroke: a prospective study in middle-aged women in Sweden. Stroke 2007, 38:27-33.
22. Morgenstern H. The changing association between social status and coronary heart disease in a rural population. Soc Sci Med Med Psychol Med Sociol 1980, 14A:191-201.
23. Kunst A.E., del Rios M., Groenhof F., Mackenbach J.P. Socioeconomic inequalities in stroke mortality among middle-aged men: an international overview. European Union Working Group on Socioeconomic Inequalities in Health. Stroke 1998, 29:2285-2291.
24. Stringhini S., Viswanathan B., Gedeon J., Paccaud F., Bovet P. The social transition of risk factors for cardiovascular disease in the African region: evidence from three cross-sectional surveys in the Seychelles. Int J Cardiol 2013, 168:1201-1206.
25. Ziraba A.K., Fotso J.C., Ochako R. Overweight and obesity in urban Africa: a problem of the rich or the poor?. BMC Public Health 2009, 9:465.
26. Jones-Smith J.C., Gordon-Larsen P., Siddiqi A., Popkin B.M. Is the burden of overweight shifting to the poor across the globe? Time trends among women in 39 low- and middle-income countries (1991-2008). Int J Obes (Lond) 2012, 36:1114-1120.
27. Global Strategy for the Prevention and Control of Noncommunicable Diseases (NCDs) (WHA A53/14) 2000, World Health Assembly, World Health Organization, Geneva.
28. Hosseinpoor A.R., Parker L.A., Tursan d'Espaignet E., Chatterji S. Social determinants of smoking in low- and middle-income countries: results from the World Health Survey. PLoS One 2011, 6:e20331.
29. Dodani S., Mistry R., Khwaja A., et al. Prevalence and awareness of risk factors and behaviours of coronary heart disease in an urban population of Karachi, the largest city of Pakistan: a community survey. J Public Health (Oxf) 2004, 26:245-249.
30. Dubowitz T., Heron M., Bird C.E., et al. Neighborhood socioeconomic status and fruit and vegetable intake among whites, blacks, and Mexican Americans in the United States. Am J Clin Nutr 2008, 87:1883-1891.
31. The World Health Report - Health System Financing 2010, World Health Organization, WHO, Geneva.
32. Commission on the Social Determinants of Health 2008, World Health Organization, WHO, Geneva.
33. How we classify countries? 2011, The World Bank, The World Bank, Washington, DC.
34. The World Bank. World Development Indicators Database. Available at:. Accessed July 30, 2015. http://data.worldbank.org/indicator/NY.GNP.PCAP.CD/countries.
35. World Bank. New Country Classifications. Available at:. Accessed July 30, 2015. http://data.worldbank.org/news/new-country-classifications.
36. Ebrahim S., Pearce N., Smeeth L., et al. Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need?. PLoS Med 2013, 10:e1001377.
37. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Total Cardiovascular Risk 2007, World Health Organization, World Health Organization, Geneva.
38. Leeder S, Raymond S, Greenberg H. A race against time. The challenge of cardiovascular diseases in developing economies. Available at:. Accessed July 30, 2015. http://earth.columbia.edu/news/2004/images/raceagainsttime_FINAL_051104.pdf.
39. World Health Organization. Projections of mortality and burden of disease, 2004-2030. Available at:. Accessed July 30, 2015. http://www.who.int/healthinfo/global_burden_disease/projections2004/en/.
40. World Health Organization. Preventing chronic disease: a vital assessment. Available at:. Accessed July 30, 2015. http://www.who.int/chp/chronic_disease_report/full_report.pdf.
41. Bygbjerg I.C. Double burden of noncommunicable and infectious diseases in developing countries. Science 2012, 337:1499-1500.
42. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385:117-171. GBD 2013 Mortality and Causes of Death Collaborators.
43. Beaglehole R., Yach D. Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet 2003, 362:903-908.
44. Danaei G., Finucane M.M., Lu Y., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378:31-40.
45. Farzadfar F., Finucane M.M., Danaei G., et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 2011, 377:578-586.
46. Finucane M.M., Stevens G.A., Cowan M.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
47. Danaei G., Finucane M.M., Lin J.K., et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011, 377:568-577.
48. Anand S.S., Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet 2011, 377:529-532.
49. Nikolic I.A., Stanciole A.E., Zaydman M. Chronic emergency: why NCDs matter 2011, The International Bank for Reconstruction and Development - The World Bank, Washington DC.
50. Mendis S. Epidemiology, global public health; the need for equitable action to address cardiovascular diseases. Atherosclerosis: The 21st Century Epidemic 2011, The Pontifical Academy of Sciences, Vatican City. C.J. Estol, M.S. Sorondo (Eds.).
51. Bobadilla J.L., Frenk J., Lozano R., et al. The epidemiologic transition and health priorities. Disease Control Priorities in Developing Countries 1993, 351-356. Oxford University Press, New York, NY. D.T. Jamison (Ed.).
52. Kaplan G.A., Keil J.E. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993, 88:1973-1998.
53. Yusuf S., Reddy S., Ounpuu S., Anand S. Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001, 104:2746-2753.
54. Okpechi I.G., Swanepoel C.R., Venter F. Access to medications and conducting clinical trials in LMICs. Nat Rev Nephrol 2015, 11:189-194.
55. Lucero A.A., Lambrick D.M., Faulkner J.A., et al. Modifiable cardiovascular disease risk factors among indigenous populations. Adv Prev Med 2014, 2014:547018.
56. Statistics Canada. Aboriginal peoples in Canada: First Nations People, Metis and Inuit. Analytical Document 99-011-x. Available at:. Accessed July 30, 2015. http://www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-011-x/99-011-x2011001-eng.cfm.
57. Atzema C.L., Gravelle M.R., Kapral M., et al. Cardiovascular Disease in the Métis Nation of Ontario 2010, Institute for Clinical Evaluative Sciences (Technical Report), Available at: http://www.metisnation.org/media/229147/mno%20cardiovascular%20clinical%20significance%20report(29_mar_2012).pdf. Accessed July 30, 2015.
58. Garner R., Carriere G., Sanmartin C. The health of First Nations living off-reserve, Inuit, and Métis adults in Canada: the impact of socio-economic status on inequalities in health 2010, Statistics Canada (working paper), 82-622-X no. 004.
59. Beiser M., Stewart M. Reducing health disparities, a priority for Canada. Can J Public Health 2005, 96(suppl 2):S4-S5.
60. Shah B.R., Cauch-Dudek K., Fangyun Wu C. Diabetes in the Métis Nation of Ontario (Technical Report) 2010, Institute for Clinical Evaluative Sciences.
61. Anand S.S., Tookenay V. Cardiovascular diseases in Aboriginal Canadians. Canadian Cardiovascular Society Consensus Paper. Can J Cardiol 1999, 15(suppl):44G-46G.
62. Howard B.V., Lee E., Cowan L., et al. Rising tide of cardiovascular disease in American Indians: the Strong Heart Study. Circulation 1999, 99:2389-2395.
63. Shah B.R., Hux J.E., Zinman B. Increasing rates of ischemic heart disease in the native population of Ontario, Canada. Arch Intern Med 2000, 160:1862-1866.
64. Anand S.S., Yusuf S., Jacobs R., et al. Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP). Lancet 2001, 358:1147-1153.
65. Tobacco use among youth: a cross country comparison. Tob Control 2002, 11:252-270. Global Youth Tobacco Survey Collaborative Group.
66. Deslisle H.F., Ekoe J.M. Prevalence of non-insulin dependent diabetes mellitus and impaired glucose intolerance in two Algonquin communities in Quebec. CMAJ 1993, 148:41-47.
67. Harris S.B., Gittelsohn J., Hanley A.J., et al. The prevalence of NIDDM and associated risk factors in Native Canadians. Diabetes Care 1997, 20:185-187.
68. Lee E., Howard B., Savage P.J., et al. Diabetes and impaired glucose tolerance in three American Indian populations age 45-74 years: The Strong Heart Study. Diabetes Care 1995, 18:599-610.
69. Gittelsohn J., Wolever T.M., Harris S.B., et al. Specific patterns of food consumption and preparation are associated with diabetes and obesity in a native Canadian population with high rates of NIDDM. J Nutr 1998, 128:541-546.
70. Harris S.B., Zinman B., Hanley A.J., et al. The impact of diabetes on cardiovascular risk factors and outcomes in a Native Canadian population. Diabetes Res Clin Pract 2002, 55:165-173.
71. Katzmarzyk P.T. Obesity and physical activity among Aboriginal Canadians. Obesity 2008, 16:184-190.
72. Sharma S., Malarcher A.M., Giles W.H., Myers G. Racial, ethnic and socioeconomic disparities in the clustering of cardiovascular disease risk factors. Ethn Dis 2004, 14:43-48.
73. Herbert K., Plugge E., Foster C., Doll H. Prevalence of risk factors for non-communicable diseases in prison populations worldwide: a systematic review. Lancet 2012, 379:1975-1982.
74. Møller L., Stöver H., Jürgens R., Gatherer A., Nikogosian H. Health in prisons: a WHO guide to the essentials in prison health 2007, World Health Organization, Geneva.
75. Lee R. The demographic transition: three centuries of fundamental change. J Econ Perspect 2003, 17:167-190.
76. Omran A.R. The epidemiologic transition: a theory of the epidemiology of population change. 1971. Milbank Q 2005, 83:731-757.
77. Sen K., Bonita R. Global health status: two steps forward, one step back. Lancet 2000, 356:577-582.
78. Leon D., Chenet L., Shkolnikov V.M., et al. Huge variation in Russian mortality rates 1984-1994: artefact, alcohol, or what?. Lancet 1997, 350:383-388.
79. King M., Smith A., Gracey M. Indigenous health part 2: the underlying causes of the health gap. Lancet 2009, 374:76-85.
80. Guindond G.E., Boisclaire D. HNP Discussion Paper Economics of Tobacco Control Paper No. 6 Past, Current and Future Trends in Tobacco use 2003, The World Bank, Washington DC.
81. Toll B.A., Ling P.M. The Virginia Slims identity crisis: an inside look at tobacco industry marketing to women. Tob Control 2005, 14:172-180.
82. Moussavi S., Chatterji S., Verdes E., Tandon A., Patel V. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007, 370:851-858.
83. Kanjilal S., Gregg E.W., Cheng Y.J., et al. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med 2006, 166:2348-2355.
84. Global Risks 2010: A Global Risk Network Report 2010, World Economic Forum (WEF), World Economic Forum, Geneva.
85. Stuckler D., Basu S., McKee M. Drivers of inequality in millennium development goal progress: a statistical analysis. PLoS Med 2010, 7:e1000241.
86. Galobardes B., Smith G.D., Lynch J.W. Systematic review of the influence of childhood socioeconomic circumstances on risk for cardiovascular disease in adulthood. Ann Epidemiol 2006, 16:91-104.
87. Cox A.M., McKevitt C., Rudd A.G., Wolfe C.D. Socioeconomic status and stroke. Lancet Neurol 2006, 5:181-188.
88. Hemingway H., Shipley M., Mullen M.J., et al. Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). Am J Cardiol 2003, 92:984-987.
89. Pollitt R.A., Rose K.M., Kaufman J.S. Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review. BMC Publ Health 2005, 20:5-7.
90. Weintraub W.S., Daniels S.R., Burke L.E., et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation 2011, 124:967-990.
91. McLaren L., McIntyre L., Kirkpatrick S. Rose's population strategy of prevention need not increase social inequalities in health. Int J Epidemiol 2010, 39:372-377.
92. Law M. Lipids and cardiovascular disease. Evidence Based Cardiology 1998, 191-205. BMJ Books, London, UK. S. Yusuf, J.A. Cairns, J.A. Camm (Eds.).
93. Ebrahim S. What is the best strategy for reducing deaths from heart disease?. PLoS Med 2005, 2:e98.
94. Capewell S., Jackson R. Will screening individuals at high risk of cardiovascular events deliver large benefits? No. BMJ 2008, 337:a1395.
95. Unal B., Critchley J., Capewell S. Modelling the decline in CHD deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention. BMJ 2005, 331:614-615.
96. Kivimäki M., Shipley M.J., Ferrie J.E., et al. Estimating the impact of 'best-practice' interventions on reducing socioeconomic inequalities in coronary heart disease mortality in a working population: the Whitehall study. Lancet 2008, 372:1648-1654.
97. Townsend J., Roderick P., Cooper J. Cigarette smoking by socioeconomic group, sex, and age: effects of price, income, and health publicity. BMJ 1994, 309:923-927.
98. Main C., Thomas S., Ogilvie D., et al. Population tobacco control interventions and their effects on social inequalities in smoking: placing an equity lens on existing systematic reviews. BMC Public Health 2008, 8:178.
99. Frohlich K.L., Potvin L. The inequality paradox: the population approach and vulnerable populations. Am J Public Health 2008, 98:216-221.
100. Tugwell P., de Savigny D., Hawker G., Robinson V. Applying clinical epidemiological methods to health equity: the equity effectiveness loop. BMJ 2006, 332:358-361.
101. Committee on Preventing the Global Health Epidemic of Cardiovascular Disease: meeting challenges in developing countries. Promoting cardiovascular health in the developing world: a critical challenge to achieve global health 2010, Institute of Medicine, National Academies Press, Washington DC. V. Fuster, B.B. Kelly (Eds.).
102. Bovet P., Gervasoni J.P., Mkamba M., et al. Low utilization of health care services following screening for hypertension in Dar es Salaam (Tanzania): a prospective population-based study. BMC Public Health 2008, 8:407.
103. Lonn E., Bosch J., Teo K.K., et al. The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions. Circulation 2010, 122:2078-2088.
104. Pan American Health Organization / World Health Organization. 28th Pan American Sanitary Conference, 64th Session of the Regional Committee. Strategy for the Prevention and Control of Noncommunicable Diseases. Available at:. Accessed July 30, 2015. http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=21345&Itemid.
105. Morgan S., Law M., Daw J., Abraham L., Martin D. Estimated cost of universal public coverage of prescription drugs in Canada. CMAJ 2015, 187:491-497.
106. Anyangwe S.C., Mtonga C. Inequities in the global health workforce: the greatest impediment to health in sub-Saharan Africa. Int J Environ Res Public Health 2007, 4:93-100.
107. Mayosi B. The 10 'Best Buys' to Combat Heart Disease, Diabetes and Stroke in Africa. Available at:. Accessed February 27, 2015. http://heart.bmj.com/content/early/2013/05/16/heartjnl-2013-304130.full.pdf+htm.
108. Joshi R., Alim M., Kengne A., et al. Task shifting for non-communicable disease management in low and middle income countries - a systematic review. Plos One 2014, 9:e103754.
109. Ogedegbe G., Gyamfi J., Plange-Rhule J., et al. Task shifting interventions for cardiovascular risk reduction in low-income and middle-income countries: a systematic review of randomised controlled trials. BMJ Open 2014, 4:e005983.
110. Gorter AC, Meessen B. Evidence Review, Results-Based Financing of Maternal and Newborn Health Care in Low-and Lower-Middle-Income Countries. February 2013, study commissioned and funded by the German Federal Ministry for Economic Cooperation and Development (BMZ) through the sector project PROFILE at GIZ-Deutsche Gesellschaft für Internationale Zusammenarbeit. Available at:. Accessed July 30, 2015. http://www.oecd.org/dac/peer-reviews/Evidence-RBF-maternal-health.pdf.
111. Witter S., Fretheim A., Kessy F.L., Lindahl A.K. Paying for performance to improve the delivery of health interventions in low-and middle-income countries. Cochrane Database Syst Rev 2012, 2:CD007899.
112. Musgrove P. Financial and Other Rewards for Good Governance or Results: A Guided Tour of Concepts and Terms and a Short Glossary 2011, World Bank, Washington.
113. Toonen J., Canavan A., Vergeer P., Elovainio R. Learning lessons on implementing performance-based financing: from a multi-country evaluation 2009, KIT Development Policy & Practice, Amsterdam.
114. Basinga P., Gertler P.J., Binagwaho A., et al. Effect on maternal and child health services in Rwanda of payment to primary health-care providers for performance: an impact evaluation. Lancet 2011, 377:1421-1428.
115. Fernald L.C., Gertler P.J., Neufeld L.M. Role of cash in conditional cash transfer programmes for child health, growth, and development: an analysis of Mexico's Oportunidades. Lancet 2008, 371:828-837.
116. Beane C.R., Hobbs S.H., Thirumurthy H. Exploring the potential for using results-based financing to address non-communicable diseases in low-and middle-income countries. BMC Public Health 2013, 13:92.
117. Vanzie M., Hsi N., Beith A., Eichler R. Using Supply-Side Pay for Performance to Strengthen Health Prevention Activities and Improve Efficiency: The Case of Belize 2010, Health Systems 20/20, Bethesda, MD.
118. Benderly B. Belize Fights NCDs with P4P, RBF Blog. The World Bank: Results-Based Financing for Health 2011.
119. Garside J. More mobile devices than people 'within five years.' Available at:. Accessed April 15, 2015. http://www.guardian.co.uk/business/2012/jun/06/more-mobile-devices-people-five-years.
120. WHO Global Observatory for eHealth. New horizons for health through mobile technologies 2011, World Health Organization, Geneva.
121. Pop-Eleches C., Thirumurthy H., Habyarimana J.P., et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS 2011, 25:825-834.
122. Cole-Lewis H., Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev 2010, 32:56-69.
123. Lester R.T., Ritvo P., Mills E.J., et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2010, 376:1838-1841.
124. Beratarrechea A., Lee A.G., Willner J.M., et al. The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review. Telemed J E Health 2014, 20:75-82.
125. Ogedegbe G., Plange-Rhule J., Gyamfi J., et al. A cluster-randomized trial of task shifting and blood pressure control in Ghana: study protocol. Implement Sci 2014, 9:73.
126. Praveen D., Patel A., McMahon S., et al. A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Implement Sci 2013, 8:137.
127. Marr M., et al. I-RREACH: an engagement and assessment tool for improving implementation readiness of researchers, organizations and communities in complex interventions. Implement Sci 2015, 10:64.